Cargando…
Late onset of neutral lipid storage disease due to novel PNPLA2 mutations causing total loss of lipase activity in a patient with myopathy and slight cardiac involvement
Neutral lipid storage disease with myopathy (NLSDM) presents with skeletal muscle myopathy and severe dilated cardiomyopathy in nearly 40% of cases. NLSDM is caused by mutations in the PNPLA2 gene, which encodes the adipose triglyceride lipase (ATGL). Here we report clinical and genetic findings of...
Autores principales: | Missaglia, Sara, Maggi, Lorenzo, Mora, Marina, Gibertini, Sara, Blasevich, Flavia, Agostoni, Piergiuseppe, Moro, Laura, Cassandrini, Denise, Santorelli, Filippo Maria, Gerevini, Simonetta, Tavian, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pergamon Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424884/ https://www.ncbi.nlm.nih.gov/pubmed/28258942 http://dx.doi.org/10.1016/j.nmd.2017.01.011 |
Ejemplares similares
-
Severe cardiomyopathy in a young patient with complete deficiency of adipose triglyceride lipase due to a novel mutation in PNPLA2 gene
por: Pasanisi, Maria Barbara, et al.
Publicado: (2016) -
A novel PNPLA2 mutation causing total loss of RNA and protein expression in two NLSDM siblings with early onset but slowly progressive severe myopathy
por: Tavian, Daniela, et al.
Publicado: (2019) -
PLIN4-related myopathy: clinical, histological and imaging data in a large cohort of patients
por: Maggi, Lorenzo, et al.
Publicado: (2023) -
Neutral lipid storage disease with myopathy: A 10-year follow-up case report
por: Missaglia, Sara, et al.
Publicado: (2022) -
VCP-related myopathy: a case series and a review of literature
por: Iannibelli, Eliana, et al.
Publicado: (2023)